European trial on Optical Coherence Tomography Optimized Bifurcation Event Reductio

Recruiting

• Conditions: Bifurcation lesion; 10011082

• Registration Number: NL-OMON55628
• Lead Sponsor: Aarhus University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 140

Inclusion Criteria

Stable angina pectoris, unstable angina pectoris, clinically stable non-STEMI.
Age >=18 yrs.
Abel to provide written Informed consent and willing to comply with the
specified follow-up contacts.

Exclusion Criteria

STEMI within 72 hours
Cardiogenic shock
Prior CABG or planned CABG
Renal failure with GFR<50 mL/min per 1.73 m2
Active bleeding or coagulopathy
Life expectancy < 2 years
Ejection fraction < 30%
NYHA class > II
Relevant allergies (aspirin, clopidogrel, ticagrelor, contrast compounds,
everolimus).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Combined endpoint of median two-year MACE (cardiac death, target lesion<br /><br>myocardial infarction, ischemic driven target lesion revascularization)</p><br>